Browsing: Novo
The blockbuster diabetes drug Ozempic could be manufactured for less than $5 a month, even as Novo Nordisk charges close…
BAGSVÆRD, Denmark – Novo Nordisk (NYSE:), a global healthcare company, has announced its agreement to purchase Cardior Pharmaceuticals for up…
In a series of transactions this week, Novo Holdings A/S, a significant shareholder in Spruce Biosciences, Inc. (NASDAQ:SPRB), has sold…
© 2024 American CEO Club. All Rights Reserved.